International Journal of Radiation Oncology * Biology * Physics
Volume 64, Issue 4 , Pages 1023-1030 , 15 March 2006

Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: Determinants of response and its prognostic value for subsequent survival

Presented in part at the Ninth Annual Scientific Meeting of the Society for Neuro-Oncology, Toronto, Canada, November 2004, and the 46th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Atlanta, GA, October 3–7, 2004.

  • Baldassarre Stea, M.D., Ph.D.

      Affiliations

    • University of Arizona Health Sciences Center, Tucson, AZ
    • Corresponding Author InformationReprint requests to: Baldassarre Stea, M.D., Ph.D., The University of Arizona Health Sciences Center, Department of Radiation Oncology, 1501 North Campbell Avenue, Tucson, AZ 85724. Tel: (520) 694-7236; Fax: (520) 626-3141
    • ,
  • John H. Suh, M.D.

      Affiliations

    • Cleveland Clinic, Cleveland, OH
    • ,
  • Adam P. Boyd, M.S.

      Affiliations

    • Allos Therapeutics, Inc., Westminster, CO
    • ,
  • Pablo J. Cagnoni, M.D.

      Affiliations

    • Allos Therapeutics, Inc., Westminster, CO
    • ,
  • Edward Shaw, M.D.

      Affiliations

    • Wake Forest University School of Medicine, Winston-Salem, NC
    • ,
  • REACH Study Group

Received 22 August 2005 ,Revised 11 October 2005 ,Accepted 11 October 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Sponsored by Allos Therapeutics, Inc., Westminster, Colorado.

PII: S0360-3016(05)02739-2

doi: 10.1016/j.ijrobp.2005.10.004

International Journal of Radiation Oncology * Biology * Physics
Volume 64, Issue 4 , Pages 1023-1030 , 15 March 2006

Article Tools

* Image Usage & Resolution